MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Is lowering stimulation frequency a feasible option to improve speech in Parkinson’s disease patients undergoing subthalamic deep brain stimulation?

M. Fabbri, M. Zibetti, G. Ferrero, A. Accornero, I. Guimaraes, M. Rizzone, A. Romagnolo, J. Ferreira, L. Lopiano (Lisbon, Portugal)

Meeting: 2018 International Congress

Abstract Number: 572

Keywords: Deep brain stimulation (DBS), Parkinsonism

Session Information

Date: Saturday, October 6, 2018

Session Title: Surgical Therapy: Parkinson's Disease

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To analyzse the effect of low frequency (LFS) subthalamic nucleus deep brain stimulation (STN-DBS) on speech and voice in Parkinson’s disease (PD) patients with medium/long term post-surgical follow-up.

Background: STN-DBS has an optimal effect on cardinal motor symptoms of PD. Nevertheless, its long-term effect on dysarthria is not clear. Few studies, with small patients samples, suggest a transient beneficial effect of LFS on PD dysarthria. Though data in this area are scarce [1].

Methods: 20 PD patients who underwent STN-DBS at least 3 years before, divided into two groups, matched for gender, age and age at disease onset (Group A: slight speech impairment [MDS-UPDRS item 2.1 ≤ 2] and group B: severe speech impairment [MDS-UPDRS item 2.3 ≥ 3] were tested in the following conditions: MED OFF/STIM ON (130Hz – standard frequency), MED OFF/STIM OFF and MED OFF/STIM ON (60Hz – LFS). Total electrical energy delivered was maintained constant. The following was assessed in all conditions: maximum phonation time, voice quality and stability, oral diadochokinesis, speech rate and intelligibility and MDS-UPDRS-III. Voice samples were recorded and analyzed by a speech pathologist, blinded to patients’ therapeutic condition. A two weeks follow-up was performed in patients who decide to keep LFS due to a subjective and clinician rated acute improvement of speech and voice.

Results: Overall, mean (SD) age was 64.4 (±5.8) years and mean disease duration 19.4 (±4.5) years. Data on demographic, clinical, therapeutic characteristics and speech impairment impact on quality of life, are detailed in Table 1 [Table 1]. LFS compared to no stimulation (MED OFF/STIM ON at 60Hz vs MED OFF/STIM OFF) significantly improved voice quality, diadococinesis and intelligibility in Group A and diadococinesis and intelligibility in Group B, with a motor improvement (MDS-UPDRS-III) of 42±12% and 39± 22% in the two groups, respectively. On the other hand, when comparing LFS to standard frequency stimulation, there was a significant improvement of maximum phonation time, diadococinesis and intelligibility only in Group B without significant changes of motor performance. Five Group B patients opted to maintain LFS. At two weeks follow-up, two of them were kept at 60Hz stimulation, one was switched to 80 Hz and two were switched back to 130Hz, due to tremor and wearing-off reappearance.

Conclusions: LFS could be a useful option to test for STN-DBS patients with severe speech impairment. Nevertheless, its effect on motor symptoms and motor fluctuations may not be preserved over time.

References: [1] Moreau C, Pennel-Ployart O, Pinto S, Plachez A, Annic A, Viallet F, Destée A, Defebvre L. Modulation of dysarthropneumophonia by low-frequency STN DBS in advanced Parkinson’s disease. Mov Disord. 2011 Mar;26(4):659-63.

To cite this abstract in AMA style:

M. Fabbri, M. Zibetti, G. Ferrero, A. Accornero, I. Guimaraes, M. Rizzone, A. Romagnolo, J. Ferreira, L. Lopiano. Is lowering stimulation frequency a feasible option to improve speech in Parkinson’s disease patients undergoing subthalamic deep brain stimulation? [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/is-lowering-stimulation-frequency-a-feasible-option-to-improve-speech-in-parkinsons-disease-patients-undergoing-subthalamic-deep-brain-stimulation/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/is-lowering-stimulation-frequency-a-feasible-option-to-improve-speech-in-parkinsons-disease-patients-undergoing-subthalamic-deep-brain-stimulation/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley